We have located links that may give you full text access.
Reoperative Aortic Root Replacement Following Previous Cardiac Surgery or Type A Aortic Dissection Repair.
Journal of Thoracic and Cardiovascular Surgery 2024 August 24
OBJECTIVE: Reoperative aortic root replacement (ARR) is a technically challenging procedure. This study assesses the influence of reoperation on outcomes following ARR, particularly after prior acute type A aortic dissection (ATAAD) repair.
METHODS: Of the 1823 patients in this study, 1592 (87.3%) underwent primary ARR, and 231 (12.7%) underwent reoperative ARR. Within the reoperative ARR group, 69 patients (29.9%) had previous ATAAD repair, and 162 patients (70.1%) underwent reoperative ARR for other indications.
RESULTS: Reoperative ARR patients exhibited higher rates of ischemic heart disease (13.9% vs. 3%, p<0.001), diabetes (10% vs. 5.3%, p=0.009), chronic pulmonary disease (9.1% vs. 5%, p=0.018), renal impairment (17.7% vs. 5.3%, p<0.001), and had lower ejection fraction (45.5 ± 8.1 vs. 47.6 ± 7.9, p<0.001) compared to primary ARR. The overall operative mortality was 0.4%, with no significant difference between groups (0.9% vs. 0.3%, p=0.485). At multivariable analysis previous operation was the most powerful predictor for major adverse events [OR 3.20 (2.12-4.79), p<0.001]. Reoperative ARR had a lower 10-year survival compared to primary ARR (67.4% vs. 85.9%, log-rank p<0.001). Multivariable analysis further confirmed that reoperation was significantly associated with 10-year mortality [HR 1.76 (1.01-3.06), p=0.044]. Among the reoperative ARR group, operative mortality after previous ATAAD repair was similar to that for other etiologies (0% v 1.2%, p=0.880).
CONCLUSION: Patients undergoing reoperative ARR have more comorbidities and extensive aortic disease compared to those undergoing primary surgery. They face a 3.5-fold increased risk of major adverse events but no difference in operative mortality compared to primary ARR.
METHODS: Of the 1823 patients in this study, 1592 (87.3%) underwent primary ARR, and 231 (12.7%) underwent reoperative ARR. Within the reoperative ARR group, 69 patients (29.9%) had previous ATAAD repair, and 162 patients (70.1%) underwent reoperative ARR for other indications.
RESULTS: Reoperative ARR patients exhibited higher rates of ischemic heart disease (13.9% vs. 3%, p<0.001), diabetes (10% vs. 5.3%, p=0.009), chronic pulmonary disease (9.1% vs. 5%, p=0.018), renal impairment (17.7% vs. 5.3%, p<0.001), and had lower ejection fraction (45.5 ± 8.1 vs. 47.6 ± 7.9, p<0.001) compared to primary ARR. The overall operative mortality was 0.4%, with no significant difference between groups (0.9% vs. 0.3%, p=0.485). At multivariable analysis previous operation was the most powerful predictor for major adverse events [OR 3.20 (2.12-4.79), p<0.001]. Reoperative ARR had a lower 10-year survival compared to primary ARR (67.4% vs. 85.9%, log-rank p<0.001). Multivariable analysis further confirmed that reoperation was significantly associated with 10-year mortality [HR 1.76 (1.01-3.06), p=0.044]. Among the reoperative ARR group, operative mortality after previous ATAAD repair was similar to that for other etiologies (0% v 1.2%, p=0.880).
CONCLUSION: Patients undergoing reoperative ARR have more comorbidities and extensive aortic disease compared to those undergoing primary surgery. They face a 3.5-fold increased risk of major adverse events but no difference in operative mortality compared to primary ARR.
Full text links
Related Resources
Trending Papers
Molecular Therapeutics for Diabetic Kidney Disease: An Update.International Journal of Molecular Sciences 2024 September 19
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app